The goal of the Study Group is to bring together researchers in academia, hospitals and industry to exchange data and expertise in order to advance the understanding of the physiology of incretin and related hormones and their role in the pathogenesis and treatment of metabolic and other diseases.
The overall aim of the European Incretin Study Group is to extend our understanding of the broader incretin field and to disseminate relevant information to the wider scientific community.
Please, go to the website for all information regarding the meeting organization, registration, abstract submission.
Be aware that abstract submission is open until June 30th, 2022.
Program and details of the event: https://wp.unil.ch/incretin-studygroup2022/